bf/NASDAQ:RNA_icon.jpeg

NASDAQ:RNA

Avidity Biosciences

  • Stock

32.69

+0.12%

−13.78

USD last updated 16/08 01:55:59

Last Close

46.47

15/08 20:48

Market Cap

4.07B

Beta: −0.10

Volume Today

1.06M

Avg: 1.32M

PE Ratio

−4.46

PFCF: −4.85

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-302020-03-312021-08-092023-05-092024-08-132025-06-13

    Revenue (Estimate*)

    2M4M6M8M10M12M2019-03-302020-03-312021-08-092023-05-092024-08-132025-06-13

    *Estimate based on analyst consensus